GLP-1 receptor PAM (Addex)

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameGLP-1 receptor PAM (Addex)
Drug Alias NameGLP1R PAM (Addex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin release stimulantsGlucagon-like peptide 1 receptor modulators
TargetsInsulin receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A